Bivalirudin (Hospira, Inc.)


Welcome to the PulseAid listing for the Bivalirudin drug offered from Hospira, Inc.. This Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: BIVALIRUDIN
SUBSTANCE NAME: BIVALIRUDIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anti-coagulant [EPC],Direct Thrombin Inhibitor [EPC],Thrombin Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-07-30
END MARKETING DATE: 0000-00-00


Bivalirudin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBivalirudin from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250(mg/1)
START MARKETING DATE: 2015-07-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-8300_264eb68f-64f7-4d47-b158-c1544f3bbe29
PRODUCT NDC: 0409-8300
APPLICATION NUMBER: ANDA090811

Other BIVALIRUDIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex corpBivalirudin
Dr. Reddy’s Laboratories LimitedBivalirudin
Fresenius Kabi USA, LLCBivalirudin
Hospira, Inc.Bivalirudin
Sagent Pharmaceuticalsbivalirudin
Sandozbivalirudin
The Medicines CompanyAngiomax